title: Influenza update 2007-2008: vaccine advances, pandemic preparation.
abstract: Influenza vaccination remains our best measure to prevent epidemic and pandemic influenza. We must continue to improve vaccination rates for targeted populations. Antiviral options are currently limited to the neuraminidase inhibitors.
authors.affiliation: Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA. mossads@ccf.org
authors.forename: Sherif B
authors.initials: SB
authors.lastname: Mossad
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D001717:Birds; D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000600:supply & distribution; D005585:Influenza in Birds; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D014481:United States / Q000453:epidemiology
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines; D009439:Neuraminidase